Abstract
Introduction: Sugammadex is a cyclodextrin that reverses neuromuscular blockade, especially of rocuronium. The occurrence of anaphylaxis produced by its use is of 1:1000 and 1:20000; it is observed mainly in subjects of Asian origin.
Case report: A 9-year-old boy of Asian origin who, after the administration of sugammadex, immediately manifested an episode of anaphylaxis, which was reverted by using adrenaline and antihistamines. The serum tryptase at two hours was 27.7 μg/L; at 6 weeks, it was 3 μ/L. The sugammadex 100 mg/mL skin test was positive. The basophil activation test was positive with sugammadex 20 mg/mL.
Conclusion: The temporal relationship between the administration of the drug, the clinical manifestations, the elevation of tryptase, and the diagnostic tests performed, disclosed the episode of anaphylaxis associated with hypersensitivity to sugammadex.
References
Min KC, Bondiskey P, Schulz V, Woo T, Assaid C, Yu W, et al. Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial. Br J Anaesth. 2018;121(4):749-757. DOI: 10.1016/j.bja.2018.05.056
Orihara M, Takazawa T, Horiuchi T, Sakamoto S, Nagumo K, Tomita Y, et al. Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study. Br J Anaesth. 2020;124 (2):154-163 DOI: 10.1016/j.bja.2019.10.016
Savic L, Savic S, Hopkins PM. Sugammadex: the sting in the tail? Br J Anaesth. 2018;121(4):694-697. DOI: 10.1016/j.bja.2018.07.014
Jabaley CS, Wolf FA, Lynde GC, O’Reilly-Shah V. Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study. Ther Adv Drug Saf. 2018;9(7):331-342. DOI: 10.1177/2042098618769565
de Kam PJ, Nolte H, Good S, Yunan M, Williams-Herman DE, Burggraaf J, et al. Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy nonanaesthetised volunteers. Br J Anaesth. 2018;121(4):758-767. DOI: 10.1016/j.bja.2018.05.057
Baldo BA. Anaphylaxis caused by sugammadex- rocuronium inclusion complex: what is the basis of the allergenic recognition? J Clin Anesth. 2019;54:48-49. DOI: 10.1016/j.jclinane.2018.10.017
Urra JM, Pérez-Lucendo I, Extremera A, Feo-Brito F, Alfaya T. The Method for selecting basophils might be determinant in the basophil activation test in patients with mastocytosis. J Investig Allergol Clin Immunol. 2020;30(1):65-67. DOI: 10.18176/jiaci.0442
Shen X, Hu C, Li W. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of sevoflurane and sevoflurane in combination with low-dose remifentanil. Paediatr Anaesth. 2012;22(12):1179-1184. DOI: 10.1111/j.1460-9592.2012.03906.x
Yamada T, Suzuki T, Murase R, Nagata H, Kosugi S. Anaphylactic reactions to native and light-exposed sugammadex suggested by basophil activation test: a report of 2 cases. A A Pract. 2018;11(7):181-183. DOI: 10.1213/XAA.0000000000000774
Soria A, Motamed C, Gaouar H, Chemam S, Amsler E, Francès C. Severe reaction following sugammadex injection: hypersensitivity? J Investig Allergol Clin Immunol. 2012;22(5):382. Disponible en: http://www.jiaci.org/issues/vol22issue5/8-20.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Revista Alergia México